338
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Online Traffic Analysis of Direct-to-Consumer Websites for Hair Loss Treatment and Characterization of Finasteride Patients on a Platform in Germany: A Potential Paradigm Shift in the Treatment of Androgenetic Alopecia

ORCID Icon, ORCID Icon, , , ORCID Icon, & ORCID Icon show all
Pages 937-945 | Received 18 Dec 2022, Accepted 11 Mar 2023, Published online: 05 Apr 2023

References

  • Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol. 2018;32(1):11–22. doi:10.1111/jdv.14624
  • Han SH, Byun JW, Lee WS, et al. Quality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter study. Ann Dermatol. 2012;24(3):311–318. doi:10.5021/ad.2012.24.3.311
  • Elsaie LT, Elshahid AR, Hasan HM, Soultan F, Jafferany M, Elsaie ML. Cross sectional quality of life assessment in patients with androgenetic alopecia. Dermatol Ther. 2020;33(4):e13799. doi:10.1111/dth.13799
  • Alfonso M, Richter-Appelt H, Tosti A, Viera MS, García M. The psychosocial impact of hair loss among men: a multinational European study. Curr Med Res Opin. 2005;21(11):1829–1836. doi:10.1185/030079905X61820
  • Cash TF. Attitudes, behaviors, and expectations of men seeking medical treatment for male pattern hair loss: results of a multinational survey. Curr Med Res Opin. 2009;25(7):1811–1820. doi:10.1185/03007990903005201
  • Greis C, Meier Zürcher C, Djamei V, Moser A, Lautenschlager S, Navarini AA. Unmet digital health service needs in dermatology patients. J Dermatolog Treat. 2018;29(7):643–647. doi:10.1080/09546634.2018.1441488
  • Young PC, Mahajan C, Shapiro J, Tosti A. Digital health platforms expand access and improve care for male androgenetic alopecia. Int J Dermatol. 2022;62:217–220. doi:10.1111/ijd.16452
  • Abeck F, Kött J, Wiesenhütter I, et al. Telemedical care of men with androgenetic alopecia demonstrates improved access to care and patient benefit. J Eur Acad Dermatol Venereol. 2022;36. doi:10.1111/jdv.18426
  • Wackerbarth JJ, Fantus RJ, Darves-Bornoz A, et al. Examining online traffic patterns to popular direct-to-consumer websites for evaluation and treatment of erectile dysfunction. Sex Med. 2021;9(1):100289. doi:10.1016/j.esxm.2020.100289
  • Iyengar K, Upadhyaya GK, Vaishya R, Jain V. COVID-19 and applications of smartphone technology in the current pandemic. Diabetes Metab Syndr. 2020;14(5):733–737. doi:10.1016/j.dsx.2020.05.033
  • Tabaac AR, Solazzo AL, Gordon AR, Austin SB, Guss C, Charlton BM. Sexual orientation-related disparities in healthcare access in three cohorts of U.S. adults. Prev Med. 2020;132:105999. doi:10.1016/j.ypmed.2020.105999
  • Dalia Research. LGBT Population in Europe; 2016. Available from: https://daliaresearch.com/wp-content/uploads/2016/11/2016-12-10_pressrel_LGBT.pdf. Accessed March 28, 2023.
  • Mysore V, Shashikumar BM. Guidelines on the use of finasteride in androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2016;82(2):128–134. doi:10.4103/0378-6323.177432
  • Andy G, John M, Mirna S, et al. Controversies in the treatment of androgenetic alopecia: the history of finasteride. Dermatol Ther. 2019;32(2):e12647. doi:10.1111/dth.12647
  • Hesseler MJ, Shyam N. Platelet-rich plasma and its utilities in alopecia: a systematic review. Dermatol Surg. 2020;46(1):93–102. doi:10.1097/DSS.0000000000001965
  • Ranpariya V, Kats D, Lipoff JB. Direct-to-consumer teledermatology growth: a review and outlook for the future. Cutis. 2022;109(4):211–217. doi:10.12788/cutis.0503